Supreme Pharmaceuticals Inc. (OTC Pink: SPRWF) engages in the production, cultivation, and sale of medical marijuana in Canada. Shares of the Canadian marijuana company have rallied over 36% over the past five trading sessions. Through early trading on Friday, September 16, 2016, Supreme Pharmaceuticals Inc. shares are rallying nearly 7%. Over the past three months, the Canadian cannabis company has seen average daily volume of 143,475 shares. However, nearly 182,500 shares or dollar volume of $133,225, has already exchanged hands through early trading Friday.
Shares of Supreme Pharmaceuticals Inc. caught a bid this week after management released news on September 14. According to the press release, Supreme Pharmaceuticals Inc. issued 130,000 incentive stock options to a consultant of the company. The report says that each option has a strike price of $0.77 and expires on September 14, 2021. Here is the press release detailing of the stock options:
Supreme Pharmaceuticals Inc. Press Release:
TORONTO, ONTARIO–(Marketwired – Sep 14, 2016) – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) has issued 130,000 stock options (each an “Option“) to a consultant of the Company. Each Option has an exercise price of $0.77 and is exercisable at any time prior to September 14th, 2021, subject to the terms and conditions of the Company’s Employee Stock Option Plan.
About Supreme Pharmaceuticals Inc.
Supreme is a Canadian publicly traded company committed to becoming a leading supplier of affordable medical cannabis through its wholly-owned subsidiary 7 ACRES (formerly AMMCan). 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating a 342,000 sq. ft. Hybrid Greenhouse facility. The Hybrid Greenhouse combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit www.supreme.ca and www.7acres.com for more information.